Your browser doesn't support javascript.
loading
A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancer.
Yam, Clinton; Rauch, Gaiane M; Rahman, Tanbin; Karuturi, Meghan; Ravenberg, Elizabeth; White, Jason; Clayborn, Alyson; McCarthy, Pamela; Abouharb, Sausan; Lim, Bora; Litton, Jennifer K; Ramirez, David L; Saleem, Sadia; Stec, James; Symmans, W Fraser; Huo, Lei; Damodaran, Senthil; Sun, Ryan; Moulder, Stacy L.
Affiliation
  • Yam C; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Dan L. Duncan Building CPB5.3542, 1515 Holcombe Blvd. Unit 1354, Houston, TX, 77030, USA.
  • Rauch GM; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rahman T; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Karuturi M; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Dan L. Duncan Building CPB5.3542, 1515 Holcombe Blvd. Unit 1354, Houston, TX, 77030, USA.
  • Ravenberg E; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Dan L. Duncan Building CPB5.3542, 1515 Holcombe Blvd. Unit 1354, Houston, TX, 77030, USA.
  • White J; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Dan L. Duncan Building CPB5.3542, 1515 Holcombe Blvd. Unit 1354, Houston, TX, 77030, USA.
  • Clayborn A; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Dan L. Duncan Building CPB5.3542, 1515 Holcombe Blvd. Unit 1354, Houston, TX, 77030, USA.
  • McCarthy P; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Dan L. Duncan Building CPB5.3542, 1515 Holcombe Blvd. Unit 1354, Houston, TX, 77030, USA.
  • Abouharb S; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Dan L. Duncan Building CPB5.3542, 1515 Holcombe Blvd. Unit 1354, Houston, TX, 77030, USA.
  • Lim B; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Dan L. Duncan Building CPB5.3542, 1515 Holcombe Blvd. Unit 1354, Houston, TX, 77030, USA.
  • Litton JK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Dan L. Duncan Building CPB5.3542, 1515 Holcombe Blvd. Unit 1354, Houston, TX, 77030, USA.
  • Ramirez DL; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Dan L. Duncan Building CPB5.3542, 1515 Holcombe Blvd. Unit 1354, Houston, TX, 77030, USA.
  • Saleem S; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Dan L. Duncan Building CPB5.3542, 1515 Holcombe Blvd. Unit 1354, Houston, TX, 77030, USA.
  • Stec J; ImmunoGen, Inc, Waltham, MA, USA.
  • Symmans WF; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Huo L; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Damodaran S; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Dan L. Duncan Building CPB5.3542, 1515 Holcombe Blvd. Unit 1354, Houston, TX, 77030, USA.
  • Sun R; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Moulder SL; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Dan L. Duncan Building CPB5.3542, 1515 Holcombe Blvd. Unit 1354, Houston, TX, 77030, USA. smoulder@mdanderson.org.
Invest New Drugs ; 39(2): 509-515, 2021 04.
Article in En | MEDLINE | ID: mdl-32984932
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoconjugates / Antibodies, Monoclonal, Humanized / Triple Negative Breast Neoplasms / Maytansine Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans Language: En Journal: Invest New Drugs Year: 2021 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoconjugates / Antibodies, Monoclonal, Humanized / Triple Negative Breast Neoplasms / Maytansine Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans Language: En Journal: Invest New Drugs Year: 2021 Document type: Article